RIPE-KG · Version 1.1.0 · Resource

ripekg:evidence-aggregation/RIPEA1195AD8EF5C09D44

https://w3id.org/ripe/ripe-kg/evidence-aggregation/RIPEA1195AD8EF5C09D44
SubjectPredicateObject
ripekg:evaluation/RIPEA1195AD8EF5C09D44 prov:wasInformedBy ripekg:evidence-aggregation/RIPEA1195AD8EF5C09D44
ripekg:evidence-aggregation/RIPEA1195AD8EF5C09D44 rdf:type rdfs:Resource
ripekg:evidence-aggregation/RIPEA1195AD8EF5C09D44 rdf:type owl:Thing
ripekg:evidence-aggregation/RIPEA1195AD8EF5C09D44 rdf:type ripe:EvidenceAggregationEvidence aggregation
ripekg:evidence-aggregation/RIPEA1195AD8EF5C09D44 rdf:type tido:Activity
ripekg:evidence-aggregation/RIPEA1195AD8EF5C09D44 prov:startedAtTime 2025-11-03T13:52:02.985079Z
ripekg:evidence-aggregation/RIPEA1195AD8EF5C09D44 prov:wasAssociatedWith ripekg:automated-agent/inspect-ai/1.0.0INSPECT-AI 1.0.0
ripekg:evidence-aggregation/RIPEA1195AD8EF5C09D44 prov:wasAssociatedWith ripekg:automated-agent/inspect-ai/1.0.0INSPECT-AI
ripekg:evidence-aggregation/RIPEA1195AD8EF5C09D44 tido:contributesTo ripekg:research-integrity-assessment/RIPEA1195AD8EF5C09D44
ripekg:publication-details/RIPEA1195AD8EF5C09D44The Cameroon Mobile Phone SMS (CAMPS) Trial: A Randomized Trial of Text Messaging versus Usual Care for Adherence to Antiretroviral Therapy prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEA1195AD8EF5C09D44
ripekg:registry-evidence/RIPEA1195AD8EF5C09D44 prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEA1195AD8EF5C09D44
ripekg:retraction-notice/35137Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEA1195AD8EF5C09D44
ripekg:retraction-notice/60864Effect of early treatment with metformin on risk of emergency care and hospitalization among patients with COVID-19: the TOGETHER randomized platform clinical trial prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEA1195AD8EF5C09D44
ripekg:study-design-evidence/RIPEA1195AD8EF5C09D44 prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEA1195AD8EF5C09D44